Peptide E Collagen
Peptide E Collagen – another of Celergen’s essential ingredients – literally rebuilds your skin from the inside out. It is easily absorbed and acts directly on the skin, making it look healthier and radiant almost immediately. Extensive clinical studies show that Peptide E Collagen provides the following health benefits:
I. Reduction of Lines and Wrinkles
Made up of the 2 main components of outer skin layers, collagen and elastin, Peptide E Collagen is easily absorbed, lifting and toning slack areas, improving hydration and skin thickness while also reducing lines, wrinkles and roughness.
This figure shows the effect of 2 grams/day of Peptide E Collagen given orally for 28 days on forearm wrinkles and crow’s feet in 43 healthy female volunteers, aged 40-55 years.
At 28 days, 71% of subjects in the Peptide E Collagen group showed a significant decrease in the number of deep wrinkles. The average deep wrinkle reduction was equal to 10%. On the other hand, the control group showed further damage to their skin in the same period with a significant increase in deep wrinkles by 28% in 82% of subjects.
In other words, Peptide E Collagen rebuilds outer skin layers from the inside out and make your skin toned, supple and well hydrated while also reducing lines, wrinkles and roughness.
II. Reduction in Swollen Joints in Rheumatoid Arthritis
Rheumatoid arthritis is an autoimmune inflammatory disease in which immune T cells react to type II collagen, damaging synovial membrane in the joint. The membrane slowly becomes thicker, destroying cartilage and other joint structures.
In a clinical trial conducted in 1993, hydrolyzed collagen was shown to reduce the number of swollen and tender joints in patients with severe rheumatoid arthritis. Hydrolyzed collagen is easily digested and absorbed by the body. This, along with its ability to accumulate in cartilage, makes Peptide E Collagen a powerful ingredient for alleviating the symptoms of rheumatoid arthritis.
Rheumatoid arthritis is an autoimmune inflammatory disease in synovial membrane in the joint is severely damaged. Type II collagen is the major protein in articular cartilage and is a potential auto-antigen in this disease.
In a randomized, double-blind clinical trial conducted in 1993, hydrolyzed collagen was shown to reduce the number of swollen and tender joints in patients with severe rheumatoid arthritis. 60 patients with severe, active rheumatoid arthritis reported a decrease in the number of swollen and tender joints after consuming chicken type II collagen for 3 months, without any side effects. This effect was not seen in patients who received a placebo. Not only that, four patients in the collagen group had complete remission of the disease.
III. Reduction of Pain and Inflammation in Fibromyalgia
Fibromyalgia is the second most common rheumatologic disease condition after osteoarthritis. Peptide E Collagen actively inhibits transmission of pain and contributes to reducing the discharge of inflammatory factors and neurotransmitters in the joint. Peptide E Collagen also reduces pain by allowing collagen fibers to reform and improving the overall condition of the cartilage.
Finally, hydrolyzed collagen is easily digested and absorbed by the body. This, along with its analgesic and anti-inflammatory activity and ability to accumulate in cartilage, suggests that Peptide E Collagen may be useful in the treatment of fibromyalgia.
Addition of chondroitin sulfate will improve cellular development, while glucosamine will provide protection for the cartilage and has an additional anti-inflammatory effect.